Mike Schnall-Levin, PhD

2006 Hertz Fellow
Find me on LinkedIn

Michael Schnall-Levin is the Chief Technology Officer and Founding Scientist at 10x Genomics, where he has been since the company’s inception in 2012.

In that role, he is responsible for 10x’s technology strategy, including setting the internal technology and product roadmap as well as leading external technology evaluation resulting in licensing and M&A. He also leads the research and development groups at 10x that develop new products in single cell and spatial analysis.

Before joining 10x Genomics, Michael was a NSF postdoctoral fellow with Eric Lander at the Broad Institute, where he worked on developing novel applications of DNA sequencing technologies. Prior to that, Michael worked at Foundation Medicine, where he developed some of the early algorithms to accurately detect mutations in patient tumor samples. Michael earned his Ph.D in Mathematics from MIT with Bonnie Berger, where he was both a Hertz fellow and NDSEG fellow, and his B.A. in Physics from Harvard College

“Other Hertz fellows have been a very valuable resource for me. Collectively, there is expertise on almost any subject, and it has been useful to know people to contact for help with research questions."
– Michael Schnall-Levin

Hertz Foundation Role

Board of Directors

Graduate Studies

Massachusetts Institute of Technology
Biology
RNA: Algorithms, Evolution and Design

Undergraduate Studies

Harvard University

Related News

Dec 31, 2021
As part of the Hertz Foundation's 2021 Philanthropy Report, shares how he uses the success of his company, 10x Genomics to pay it forward to other Hertz Fellows.

Related Events

e.image.alt
Jan 24, 2024 - Jan 24, 2023
Innovation Hour
At the January 2024 Innovation Hour, Hertz Fellow Michael Schnall-Levin, Chief Technology Officer and Founding Scientist at 10x Genomics, will discuss the single cell, in situ and spatial technologies in development by his company to enable advances in human health with applications to oncology, neuroscience, immunology and more.   

How Mike is Making an Impact

Tools for Studying Cancer Arrow Right